ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Manufacturing and Development Services Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-21E16188
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Peptide Manufacturing and Development Services Market Research Report 2023
BUY CHAPTERS

Global Peptide Manufacturing and Development Services Market Research Report 2025

Code: QYRE-Auto-21E16188
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
GenScript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific

Peptide Manufacturing and Development Services Market Size

The global market for Peptide Manufacturing and Development Services was valued at US$ 2558 million in the year 2024 and is projected to reach a revised size of US$ 4435 million by 2031, growing at a CAGR of 8.3% during the forecast period.

Peptide Manufacturing and Development Services Market

Peptide Manufacturing and Development Services Market

Peptide manufacturing and development services refer to specialized services provided by companies and organizations involved in the production and development of peptides, which are short chains of amino acids. These services cater to a wide range of industries, including pharmaceuticals, biotechnology, cosmetics, and research.
Peptide manufacturing and development services constitute a rapidly growing market within the biopharmaceutical sector. With the continuous advancement of global biotechnology and pharmaceutical research, peptides, as crucial components of therapeutic drugs, are experiencing a rising demand. The market size is expanding, and sales are consistently increasing. Providers of peptide manufacturing and development services offer pharmaceutical companies and research institutions high-quality, customized solutions for peptide synthesis and development, catering to diverse therapeutic areas. In the future, with ongoing innovations in biopharmaceutical technology, specific uses of peptides in fields such as oncology, immunomodulation, and neuroscience are expected to further expand, presenting significant development opportunities for the peptide manufacturing and development services market.
This report aims to provide a comprehensive presentation of the global market for Peptide Manufacturing and Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Manufacturing and Development Services.
The Peptide Manufacturing and Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Manufacturing and Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Manufacturing and Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide Manufacturing and Development Services Market Report

Report Metric Details
Report Name Peptide Manufacturing and Development Services Market
Accounted market size in year US$ 2558 million
Forecasted market size in 2031 US$ 4435 million
CAGR 8.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • GMP Services
  • Non-GMP Services
Segment by Application
  • Commercial Production
  • Scientific Research
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peptide Manufacturing and Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide Manufacturing and Development Services Market growing?

Ans: The Peptide Manufacturing and Development Services Market witnessing a CAGR of 8.3% during the forecast period 2025-2031.

What is the Peptide Manufacturing and Development Services Market size in 2031?

Ans: The Peptide Manufacturing and Development Services Market size in 2031 will be US$ 4435 million.

Who are the main players in the Peptide Manufacturing and Development Services Market report?

Ans: The main players in the Peptide Manufacturing and Development Services Market are Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific

What are the Application segmentation covered in the Peptide Manufacturing and Development Services Market report?

Ans: The Applications covered in the Peptide Manufacturing and Development Services Market report are Commercial Production, Scientific Research, Other

What are the Type segmentation covered in the Peptide Manufacturing and Development Services Market report?

Ans: The Types covered in the Peptide Manufacturing and Development Services Market report are GMP Services, Non-GMP Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Manufacturing and Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 GMP Services
1.2.3 Non-GMP Services
1.3 Market by Application
1.3.1 Global Peptide Manufacturing and Development Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial Production
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Manufacturing and Development Services Market Perspective (2020-2031)
2.2 Global Peptide Manufacturing and Development Services Growth Trends by Region
2.2.1 Global Peptide Manufacturing and Development Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide Manufacturing and Development Services Historic Market Size by Region (2020-2025)
2.2.3 Peptide Manufacturing and Development Services Forecasted Market Size by Region (2026-2031)
2.3 Peptide Manufacturing and Development Services Market Dynamics
2.3.1 Peptide Manufacturing and Development Services Industry Trends
2.3.2 Peptide Manufacturing and Development Services Market Drivers
2.3.3 Peptide Manufacturing and Development Services Market Challenges
2.3.4 Peptide Manufacturing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Manufacturing and Development Services Players by Revenue
3.1.1 Global Top Peptide Manufacturing and Development Services Players by Revenue (2020-2025)
3.1.2 Global Peptide Manufacturing and Development Services Revenue Market Share by Players (2020-2025)
3.2 Global Peptide Manufacturing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide Manufacturing and Development Services Revenue
3.4 Global Peptide Manufacturing and Development Services Market Concentration Ratio
3.4.1 Global Peptide Manufacturing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Manufacturing and Development Services Revenue in 2024
3.5 Global Key Players of Peptide Manufacturing and Development Services Head office and Area Served
3.6 Global Key Players of Peptide Manufacturing and Development Services, Product and Application
3.7 Global Key Players of Peptide Manufacturing and Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Manufacturing and Development Services Breakdown Data by Type
4.1 Global Peptide Manufacturing and Development Services Historic Market Size by Type (2020-2025)
4.2 Global Peptide Manufacturing and Development Services Forecasted Market Size by Type (2026-2031)
5 Peptide Manufacturing and Development Services Breakdown Data by Application
5.1 Global Peptide Manufacturing and Development Services Historic Market Size by Application (2020-2025)
5.2 Global Peptide Manufacturing and Development Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide Manufacturing and Development Services Market Size (2020-2031)
6.2 North America Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
6.4 North America Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Manufacturing and Development Services Market Size (2020-2031)
7.2 Europe Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
7.4 Europe Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Manufacturing and Development Services Market Size (2020-2031)
8.2 Asia-Pacific Peptide Manufacturing and Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Manufacturing and Development Services Market Size (2020-2031)
9.2 Latin America Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
9.4 Latin America Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Manufacturing and Development Services Market Size (2020-2031)
10.2 Middle East & Africa Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide Manufacturing and Development Services Introduction
11.1.4 Bachem Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Peptide Manufacturing and Development Services Introduction
11.2.4 PolyPeptide Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.2.5 PolyPeptide Recent Development
11.3 CordenPharma
11.3.1 CordenPharma Company Details
11.3.2 CordenPharma Business Overview
11.3.3 CordenPharma Peptide Manufacturing and Development Services Introduction
11.3.4 CordenPharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.3.5 CordenPharma Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Company Details
11.4.2 AmbioPharm Business Overview
11.4.3 AmbioPharm Peptide Manufacturing and Development Services Introduction
11.4.4 AmbioPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.4.5 AmbioPharm Recent Development
11.5 USV Peptides
11.5.1 USV Peptides Company Details
11.5.2 USV Peptides Business Overview
11.5.3 USV Peptides Peptide Manufacturing and Development Services Introduction
11.5.4 USV Peptides Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.5.5 USV Peptides Recent Development
11.6 Thermofischer
11.6.1 Thermofischer Company Details
11.6.2 Thermofischer Business Overview
11.6.3 Thermofischer Peptide Manufacturing and Development Services Introduction
11.6.4 Thermofischer Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.6.5 Thermofischer Recent Development
11.7 Bio Basic
11.7.1 Bio Basic Company Details
11.7.2 Bio Basic Business Overview
11.7.3 Bio Basic Peptide Manufacturing and Development Services Introduction
11.7.4 Bio Basic Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.7.5 Bio Basic Recent Development
11.8 JPT
11.8.1 JPT Company Details
11.8.2 JPT Business Overview
11.8.3 JPT Peptide Manufacturing and Development Services Introduction
11.8.4 JPT Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.8.5 JPT Recent Development
11.9 Genscript
11.9.1 Genscript Company Details
11.9.2 Genscript Business Overview
11.9.3 Genscript Peptide Manufacturing and Development Services Introduction
11.9.4 Genscript Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.9.5 Genscript Recent Development
11.10 Xinbang Pharma
11.10.1 Xinbang Pharma Company Details
11.10.2 Xinbang Pharma Business Overview
11.10.3 Xinbang Pharma Peptide Manufacturing and Development Services Introduction
11.10.4 Xinbang Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.10.5 Xinbang Pharma Recent Development
11.11 ScinoPharm
11.11.1 ScinoPharm Company Details
11.11.2 ScinoPharm Business Overview
11.11.3 ScinoPharm Peptide Manufacturing and Development Services Introduction
11.11.4 ScinoPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.11.5 ScinoPharm Recent Development
11.12 SN Biopharm
11.12.1 SN Biopharm Company Details
11.12.2 SN Biopharm Business Overview
11.12.3 SN Biopharm Peptide Manufacturing and Development Services Introduction
11.12.4 SN Biopharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.12.5 SN Biopharm Recent Development
11.13 CBL
11.13.1 CBL Company Details
11.13.2 CBL Business Overview
11.13.3 CBL Peptide Manufacturing and Development Services Introduction
11.13.4 CBL Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.13.5 CBL Recent Development
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Details
11.14.2 Piramal Pharma Business Overview
11.14.3 Piramal Pharma Peptide Manufacturing and Development Services Introduction
11.14.4 Piramal Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.14.5 Piramal Pharma Recent Development
11.15 CPC Scientific
11.15.1 CPC Scientific Company Details
11.15.2 CPC Scientific Business Overview
11.15.3 CPC Scientific Peptide Manufacturing and Development Services Introduction
11.15.4 CPC Scientific Revenue in Peptide Manufacturing and Development Services Business (2020-2025)
11.15.5 CPC Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
GenScript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
List of Tables
 Table 1. Global Peptide Manufacturing and Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of GMP Services
 Table 3. Key Players of Non-GMP Services
 Table 4. Global Peptide Manufacturing and Development Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Peptide Manufacturing and Development Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Peptide Manufacturing and Development Services Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Peptide Manufacturing and Development Services Market Share by Region (2020-2025)
 Table 8. Global Peptide Manufacturing and Development Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Peptide Manufacturing and Development Services Market Share by Region (2026-2031)
 Table 10. Peptide Manufacturing and Development Services Market Trends
 Table 11. Peptide Manufacturing and Development Services Market Drivers
 Table 12. Peptide Manufacturing and Development Services Market Challenges
 Table 13. Peptide Manufacturing and Development Services Market Restraints
 Table 14. Global Peptide Manufacturing and Development Services Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Peptide Manufacturing and Development Services Market Share by Players (2020-2025)
 Table 16. Global Top Peptide Manufacturing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Manufacturing and Development Services as of 2024)
 Table 17. Ranking of Global Top Peptide Manufacturing and Development Services Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Peptide Manufacturing and Development Services Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Peptide Manufacturing and Development Services, Headquarters and Area Served
 Table 20. Global Key Players of Peptide Manufacturing and Development Services, Product and Application
 Table 21. Global Key Players of Peptide Manufacturing and Development Services, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Peptide Manufacturing and Development Services Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Peptide Manufacturing and Development Services Revenue Market Share by Type (2020-2025)
 Table 25. Global Peptide Manufacturing and Development Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Peptide Manufacturing and Development Services Revenue Market Share by Type (2026-2031)
 Table 27. Global Peptide Manufacturing and Development Services Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Peptide Manufacturing and Development Services Revenue Market Share by Application (2020-2025)
 Table 29. Global Peptide Manufacturing and Development Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Peptide Manufacturing and Development Services Revenue Market Share by Application (2026-2031)
 Table 31. North America Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Peptide Manufacturing and Development Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Bachem Company Details
 Table 47. Bachem Business Overview
 Table 48. Bachem Peptide Manufacturing and Development Services Product
 Table 49. Bachem Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 50. Bachem Recent Development
 Table 51. PolyPeptide Company Details
 Table 52. PolyPeptide Business Overview
 Table 53. PolyPeptide Peptide Manufacturing and Development Services Product
 Table 54. PolyPeptide Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 55. PolyPeptide Recent Development
 Table 56. CordenPharma Company Details
 Table 57. CordenPharma Business Overview
 Table 58. CordenPharma Peptide Manufacturing and Development Services Product
 Table 59. CordenPharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 60. CordenPharma Recent Development
 Table 61. AmbioPharm Company Details
 Table 62. AmbioPharm Business Overview
 Table 63. AmbioPharm Peptide Manufacturing and Development Services Product
 Table 64. AmbioPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 65. AmbioPharm Recent Development
 Table 66. USV Peptides Company Details
 Table 67. USV Peptides Business Overview
 Table 68. USV Peptides Peptide Manufacturing and Development Services Product
 Table 69. USV Peptides Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 70. USV Peptides Recent Development
 Table 71. Thermofischer Company Details
 Table 72. Thermofischer Business Overview
 Table 73. Thermofischer Peptide Manufacturing and Development Services Product
 Table 74. Thermofischer Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 75. Thermofischer Recent Development
 Table 76. Bio Basic Company Details
 Table 77. Bio Basic Business Overview
 Table 78. Bio Basic Peptide Manufacturing and Development Services Product
 Table 79. Bio Basic Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 80. Bio Basic Recent Development
 Table 81. JPT Company Details
 Table 82. JPT Business Overview
 Table 83. JPT Peptide Manufacturing and Development Services Product
 Table 84. JPT Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 85. JPT Recent Development
 Table 86. Genscript Company Details
 Table 87. Genscript Business Overview
 Table 88. Genscript Peptide Manufacturing and Development Services Product
 Table 89. Genscript Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 90. Genscript Recent Development
 Table 91. Xinbang Pharma Company Details
 Table 92. Xinbang Pharma Business Overview
 Table 93. Xinbang Pharma Peptide Manufacturing and Development Services Product
 Table 94. Xinbang Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 95. Xinbang Pharma Recent Development
 Table 96. ScinoPharm Company Details
 Table 97. ScinoPharm Business Overview
 Table 98. ScinoPharm Peptide Manufacturing and Development Services Product
 Table 99. ScinoPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 100. ScinoPharm Recent Development
 Table 101. SN Biopharm Company Details
 Table 102. SN Biopharm Business Overview
 Table 103. SN Biopharm Peptide Manufacturing and Development Services Product
 Table 104. SN Biopharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 105. SN Biopharm Recent Development
 Table 106. CBL Company Details
 Table 107. CBL Business Overview
 Table 108. CBL Peptide Manufacturing and Development Services Product
 Table 109. CBL Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 110. CBL Recent Development
 Table 111. Piramal Pharma Company Details
 Table 112. Piramal Pharma Business Overview
 Table 113. Piramal Pharma Peptide Manufacturing and Development Services Product
 Table 114. Piramal Pharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 115. Piramal Pharma Recent Development
 Table 116. CPC Scientific Company Details
 Table 117. CPC Scientific Business Overview
 Table 118. CPC Scientific Peptide Manufacturing and Development Services Product
 Table 119. CPC Scientific Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)
 Table 120. CPC Scientific Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Peptide Manufacturing and Development Services Picture
 Figure 2. Global Peptide Manufacturing and Development Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peptide Manufacturing and Development Services Market Share by Type: 2024 VS 2031
 Figure 4. GMP Services Features
 Figure 5. Non-GMP Services Features
 Figure 6. Global Peptide Manufacturing and Development Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Peptide Manufacturing and Development Services Market Share by Application: 2024 VS 2031
 Figure 8. Commercial Production Case Studies
 Figure 9. Scientific Research Case Studies
 Figure 10. Other Case Studies
 Figure 11. Peptide Manufacturing and Development Services Report Years Considered
 Figure 12. Global Peptide Manufacturing and Development Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Peptide Manufacturing and Development Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Peptide Manufacturing and Development Services Market Share by Region: 2024 VS 2031
 Figure 15. Global Peptide Manufacturing and Development Services Market Share by Players in 2024
 Figure 16. Global Top Peptide Manufacturing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Manufacturing and Development Services as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Peptide Manufacturing and Development Services Revenue in 2024
 Figure 18. North America Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
 Figure 20. United States Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
 Figure 24. Germany Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Peptide Manufacturing and Development Services Market Share by Region (2020-2031)
 Figure 32. China Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
 Figure 40. Mexico Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Peptide Manufacturing and Development Services Market Share by Country (2020-2031)
 Figure 44. Turkey Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Bachem Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 48. PolyPeptide Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 49. CordenPharma Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 50. AmbioPharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 51. USV Peptides Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 52. Thermofischer Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 53. Bio Basic Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 54. JPT Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 55. Genscript Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 56. Xinbang Pharma Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 57. ScinoPharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 58. SN Biopharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 59. CBL Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 60. Piramal Pharma Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 61. CPC Scientific Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Pharmaceutical Peptides Services Market Research Report 2025
Global Peptide Analysis Services Market Research Report 2025
Global Custom Peptide Synthesis Service Market Insights Forecast to 2030
Global Customized Peptide Synthesis Service Market Research Report 2024
Global Cyclic Peptide Service Market Research Report 2024
Global Modified Peptide Synthesis Services Market Research Report 2025
Global Customized Peptide Synthesis Market Insights Forecast to 2030
Global Peptide Microarray Service Market Research Report 2024
Global Peptide Conjugates Service Market Research Report 2024
Global Peptide CDMO Services Market Research Report 2025
Global Peptide Synthesis CDMO Services Market Research Report 2024
Global Peptide Synthesis Service Market Insights Forecast to 2030
Global mRNA Development and Manufacturing Services Market Research Report 2025
Global Peptide Screening Service Market Research Report 2025
Global Standard Peptide Custom Synthesis Service Market Research Report 2024
Global Peptide Synthesis Reagent Market Research Report 2024
Global Custom Peptide CDMO Services Market Research Report 2024
Global Chemical Synthesis Peptide Drugs Market Research Report 2024
Peptide Synthesis Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Library Construction and Screening Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions